Human MAbs from yeast

The gold standards for generating human monoclonal antibodies have been transgenic mice and phage display. Now Genetastix Corp. says it can use yeast to develop human antibodies more efficiently and at lower cost.

Last week, Hyseq Pharmaceuticals Inc. (HYSQ) obtained access to Genetastix's HuMYTech (human MAb yeast technology) for use in developing human MAbs against an undisclosed antigen (see B3). ...